Quantcast

Latest Regulus Therapeutics Inc. Stories

2015-01-08 08:28:33

Accelerates RG-101 for HCV with Dual-Track Clinical Development Strategy; Top-Line, Single Dose, 4 mg/kg Results as Well as 2mg/kg Extended Follow Up Results from Ongoing Study to be Reported in Early

2014-11-26 16:24:21

LA JOLLA, Calif., Nov. 26, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-11-15 20:21:15

- Treatment with RG-012 Protects Kidney Function and Demonstrates Additive Therapeutic Effect with Emerging Standard of Care in Preclinical Model of Alport Syndrome - LA JOLLA, Calif.,

2014-11-06 16:35:40

LA JOLLA, Calif., Nov. 6, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-11-05 16:30:38

- Demonstrated Human Proof-of-Concept; 'Clinical Map Initiative' Updated - LA JOLLA, Calif., Nov.

2014-10-30 16:29:15

LA JOLLA, Calif., Oct. 30, 2014 /PRNewswire/ -- Regulus Therapeutics Inc.

2014-10-28 20:24:05

LA JOLLA, Calif., Oct.

2014-10-27 16:27:52

LA JOLLA, Calif., Oct.

2014-10-23 08:42:56

PHOENIX, Oct. 23, 2014 /PRNewswire/ -- Insiderslab.com, a U.S.